Patents by Inventor Bernd Moosmann

Bernd Moosmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220387369
    Abstract: Prooxidative chain-transfer agents for use in the treatment of a malignant tumour disease, or infectious disease. The prooxidative chain-transfer agents are selected from lipophilic thiols, lipophilic trithiocarbonates, lipophilic, aromatic dithioesters, and lipophilic, aromatic thiols. The compounds amplify the prooxidative activity at the target site and are therefore highly efficient and specific for their targets.
    Type: Application
    Filed: November 27, 2020
    Publication date: December 8, 2022
    Inventor: Bernd Moosmann
  • Patent number: 8232243
    Abstract: The invention relates to the use of tryptophan-containing, in particular tryptophan- and tyrosine-containing, peptides as antioxidants. The compounds can be used for the therapy or prophylaxis of syndromes and disorders associated with unwanted oxidative processes in the extracellular space.
    Type: Grant
    Filed: December 4, 2000
    Date of Patent: July 31, 2012
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V.
    Inventors: Bernd Moosmann, Christian Behl
  • Publication number: 20010014695
    Abstract: Use of a tryptophanyl-ester or an N-acyl derivative of a tryptophanyl-ester for the prophylaxis and therapy of oxidative pathologic processes in degenerative diseases and/or cancer diseases. Thereby, the tryptophanyl-ester or its N-acyl derivative is preferred to be tryptophanoctyl, N-oleoyl-tryptophanethyl-ester or N-dodecanoyl-tryptophanethyl-ester.
    Type: Application
    Filed: March 16, 2001
    Publication date: August 16, 2001
    Inventors: Christian Behl, Bernd Moosmann